Pharmaceutical Manufacturing and Supply of Benzonatate Capsules

This contract involves the manufacturing and supply of Benzonatate Capsules, USP, 100 mg, packaged in bottles containing 100 capsules each. The production must adhere to stringent standards set by the FDA, Defense Logistics Agency (DLA), and military requirements for packaging and labeling. Additionally, the contractor is responsible for managing the shelf life of the product and ensuring timely delivery to Fort Bragg, North Carolina. The procurement is conducted under a subcontract and falls within the pharmaceutical manufacturing industry, specifically under NAICS code 325412. The solicitation was posted on May 19, 2026, with responses due by May 26, 2026, and is overseen by the Medical Supply Chain Pharmacy Field Support Activity (FSA) under the Department of Defense. While specific details such as points of contact or precise place of performance are not provided, the focus is clearly on meeting strict regulatory and military standards to support medical supply needs. The contract ensures readiness through compliance and logistical management for the distribution of vital pharmaceutical products to a major military installation.